RISING FDA Approval ANDA 206006

ANDA 206006

RISING

FDA Drug Application

Application #206006

Application Sponsors

ANDA 206006RISING

Marketing Status

Prescription001

Application Products

001CAPSULE; CAPSULE, DELAYED REL PELLETS; TABLET;ORAL500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG0LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCINAMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2016-10-07STANDARD
LABELING; LabelingSUPPL2AP2022-03-04STANDARD
LABELING; LabelingSUPPL3AP2022-03-04STANDARD
LABELING; LabelingSUPPL4AP2022-04-14STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL3Null15
SUPPL4Null15

TE Codes

001PrescriptionAB

CDER Filings

RISING
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206006
            [companyName] => RISING
            [docInserts] => ["",""]
            [products] => [{"drugName":"LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN","activeIngredients":"AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE","strength":"500MG,N\/A,N\/A;N\/A,500MG,N\/A;N\/A,N\/A,30MG","dosageForm":"CAPSULE; CAPSULE, DELAYED REL PELLETS; TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/07\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.